Veradigm 8K This presentation may contain forward-looking statements about | MDRX 31 Oct 06

Safe Harbor

This presentation may contain forward-looking statements about

Allscripts Healthcare Solutions that involve risks and

uncertainties. These statements are developed by combining

currently available

information

with

Allscripts’

beliefs

and

assumptions. Forward-looking statements do not guarantee future

performance. Because Allscripts cannot predict all of the risks and

uncertainties that may affect it, or control the ones it does predict,

Allscripts’

actual results may be materially different from the

results expressed in its forward-looking statements. For a more

complete discussion of the risks, uncertainties and assumptions

that may affect Allscripts, see the Company's Annual Report on

Form 10-K for the year ended December 31, 2005, available at

www.sec.gov.

900+ Employees

Financially Strong (Nasdaq: MDRX)

Established Leader in Ambulatory

Healthcare IT Market:

–

Electronic Health Records

–

Document Imaging

–

e-Prescribing

–

Practice Management

–

Connectivity Products

Three Business Groups

–

Clinical Solutions Group

–

Physicians Interactive Group

–

Medication Solutions Group

About Allscripts

The Leading Provider of

Clinical Software, Connectivity

& Information Solutions to

Physicians

A Different Approach

Traditional View

Healthcare Revolves Around

the Hospital

Our View

Healthcare Revolves Around the

Physician

Ambulatory EHR market is ~$5+ billion opportunity

~ 550,000 U.S. Physicians

X 76% EHR market opportunity

X ~$12,500 initial investment per physician

= ~$5 billion opportunity

Practice management solutions provide complementary product

offering with significant incremental market opportunity

–

~10% to 20% of PM market being replaced each year

–

PM market ~ $1 to $2 billion per year

The EHR Market

Our Solutions: World-Class Industry-Leading Technologies

Our Ability To Deliver Results: Rapid Deployment & ROI

Our Footprint: Significant Installed Base / Strong Reference Sites

Our Partners: Strong Partnerships and Strategic Alliances

Our People: Experienced Employees Who Care

Hard To Replicate Competitive Strengths

Becoming Indispensable for Physicians

•

Not Used

Costs and Waste Represent

the Problem and the Opportunity

•

Best Software

•

Best Information

•

Best Pharmaceuticals

•

Best Healthcare

•

Best Physicians

•

Not Available

•

Buried With Paperwork

•

Can’t Afford

•

Not Available to 40MM

The Paradox of Healthcare

2004

2014

16%

22%

$1.8

$3.5

The U.S. is No.1 in the world in healthcare expenditures,

but no better than 16 in medical outcomes.

($ in Trillions)

(% of GDP)

U.S. Healthcare Costs

Higher Costs and Lower Quality

Delivering Results

Generates Clinical Trial Revenue

Holston

Medical Group

$3M/Yr. in Clinical Trial Revenue

Delivers on Pay

for Performance

Facey

Medical

$1.2M P4P Payout

from Blue Cross

Produces

e-Prescribing Savings

Sierra Health

$5M in Savings via eRx

Reduces Resources in

Medical Records

George Washington Univ.

Medical Faculty Associates

Reduction of 20 FTEs in

Medical Records

Reduces/Eliminates

Transcription

Central Utah

Clinic

$1M in Savings in Year 1

($20K/MD)

Enhances

Documentation

University of Tennessee

Medical Group

Avg. Gross Charges Increases

by > $30/Patient Visit

Allscripts: The EHR of Choice

Academic

Medical Groups

Specialty

Groups

Multi-Specialty

Groups

Integrated

Delivery Networks

Over 3,000 Leading Clinics Nationwide

Large Physician

Practices (>25)

Segment

EHR

Practice

Management

Mid-size Physician

Practices (10-24)

Independent & Small

Physician Practices (<10)

Specialty Groups

Profitable Leadership In Each Segment

Leadership Across the Market

Large Physician

Practices (>25)

Segment

EHR

Practice

Management

Mid-Sized Physician

Practices (10-24)

Independent & Small

Physician Practices (<10)

Specialty Groups

Profitable Leadership In Each Segment

Primary

Competitors

Variety of

Small Players

Leadership Across the Market

Key Takeaways

The

time

now

Our

physician

focus

key

transforming

healthcare

are

leader

the

core

growth

markets

which

compete

Competitive

advantage:

driving

utilization

and

results

We’re just getting started!

Financial Overview

$20

$40

$60

$80

$100

$120

$140

$160

$180

$200

$220

$240

$260

$280

$300

$320

2004

2005

2006(E)

2007(E)

$100.8

$120.6

$225.0

$300.0

Pre-packaged

Medications

Information Services

Clinical Software and

Related Services

Growth

segments

include

Clinical

Software

and

Services

and

Information Services

Growth Segments

($ in Millions)

$20

$40

$60

$80

$100

$120

$140

$160

$180

$200

$220

$240

2004

2005

2006(E)

2007(E)

Solid Bookings Growth

Information Services

Clinical Software and

Related Services

$65.9

$89.5

$170.0

$240.0

($ in Millions)

$20

$40

$60

$80

$100

$120

$140

$160

$180

$174.0 Million

Diversified Backlog Provides Stability

$87.4

$26.6

$15.7

$44.3

($ in Millions)

As of 9/30/06

Clinical Software

Maintenance Support

Information Services

Clinical Software Subscriptions

Clinical Software License/

Implementation Fees

Accelerated Growth Continues in 2007

($ in Millions, except per share)

2005

2006 (E)

2007 (E)

Revenues:

Software & Related Services

$65.2

$170.0

$240.0

Prepackaged Medications

45.6

44.0

Information Services

9.8

11.0

16.0

Total Revenues

$120.6

$225.0

$300.0

Gross Profit

54.9

115.0

159.0

Gross Profit %

45.5%

51.1%

53.0%

Income from Operations

9.2

19.0

41.0

Net Income

$6.0

$11.3

$25.0

Weighted Average Shares Outstanding (Diluted)

43.1

54.0

64.0

Earnings per Share (Diluted)

$0.14

(1)

$0.21 to $0.22

$0.42 to $0.44

(1) 2005 has been adjusted for income taxes to provide for comparability:

$9.7 MM Net Income, or $0.23 per diluted share, as reported less 38% taxes ($3.7 MM) = $6.0 MM, or $0.14 per diluted share

Impact of Convertible Debt

(for illustrative purposes only)

($ in Millions, except per share)

Non-Converted

Converted

Non-Converted

Converted

GAAP Net Income

$11.3

$25.0

Adjustments:

Add Back Interest Expense

3.5

Tax Effect of Interest Add-back @ 38%

(1.3)

Adjusted GAAP Net Income

$11.3

$13.5

$25.0

$27.2

Diluted Shares Outstanding

54.0

56.7

Add: Convertible Debt Shares

7.3

Adjusted Diluted Shares

54.0

61.3

56.7

64.0

GAAP Earnings Per Share

$0.21

$0.22

$0.44

$0.43

Convertible Debt

Anti-dilutive

Dilutive in 2007

in 2006

2007

2006

2007 Earnings Metrics Cash Earnings

($ in Millions, except per share)

2005

2006 (E)

2007 (E)

GAAP Net Income

$9.7

$11.3

$25.0

Depreciation and Amortization

6.5

16.5

17.5

Income Taxes

0.0

7.0

16.0

Stock-Based Compensation

0.6

2.5

6.4

A4 One-Time Deal-Related Cost

0.0

1.0

0.0

Cash Earnings

16.8

38.3

64.9

Weighted Average Shares Outstanding (Diluted)

43.1

54.0

64.0

GAAP Earnings Per Share (Diluted)

$0.23

$0.21 to $0.22

$0.42 to $0.44

Cash Earnings Per Share (Diluted)

$0.39

$0.71 to $0.72

$1.04 to $1.06

2007 Earnings Metrics Adjusted Earnings

($ in Millions, except per share)

2005

2006 (E)

2007 (E)

GAAP Net Income

$9.7

$11.3

$25.0

Income Tax Provision @ 38%

($3.7)

$0.0

Acquisition-Related Amortization, net of taxes @ 38%

$1.1

$6.4

Stock-Based Compensation, net of taxes @ 38%

$0.4

$1.6

$4.0

Adjusted Earnings

$7.5

$19.3

$35.4

Weighted Average Shares Outstanding (Diluted)

43.1

54.0

64.0

GAAP Earnings Per Share (Diluted)

$0.23

$0.21 to $0.22

$0.42 to $0.44

Adjusted Earnings Per Share (Diluted)

$0.17

$0.35 to $0.36

$0.58 to $0.60

Cash & Marketable Securities

Accounts Receivable, Net

Other Assets

Total Assets

Accounts Payable & Accrued Liabilities

Deferred Revenue

Other Liabilities

Total Liabilities

Stockholders’

Equity

Financial Strength

($ in Millions)

$146.1

29.2

45.7

$221.0

$22.4

17.3

82.5

0.4

$122.6

98.4

$221.0

As of 12/31/05

As of 9/30/06

71.5

57.4

336.8

$465.7

$39.7

33.7

85.5

0.6

$159.5

306.2

$465.7

Cash & Marketable Securities

Accounts Receivable, Net

Other Assets

Total Assets

Accounts Payable & Accrued Liabilities

Deferred Revenue

Long Term Debt

Other Liabilities

Total Liabilities

Stockholders’

Equity

Total

Liabilities

Stockholders’

Equity

Summary

World-Class

Technologies

World-Class

Technologies

Return On

Investment

Return On

Investment

Our People

Proven

Track Record

Proven

Track Record

Strong

Partnerships

Strong

Partnerships

Leading

Provider of

Clinical

Solutions

Leading

Provider of

Clinical

Solutions

Physician-centric

Well-positioned

for Growth and

Sustained

Profitability

Veradigm (MDRX) 8-KThis presentation may contain forward-looking statements about